Targeting intestinal microflora in inflammatory bowel disease.
Guslandi
Mario
M
D000890:Anti-Infective Agents / Q000627:therapeutic use; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000382:microbiology / Q000628:therapy*; D007422:Intestines / Q000382:microbiology*; D019936:Probiotics / Q000627:therapeutic use*; D012294:Rifamycins / Q000627:therapeutic use; D000078262:Rifaximin
D000890:Anti-Infective Agents; D012294:Rifamycins; D000078262:Rifaximin